LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 217 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $242,000 | +11.0% | 1,566 | 0.0% | 0.04% | 0.0% |
| Q3 2021 | $218,000 | +6.3% | 1,566 | 0.0% | 0.04% | +5.9% |
| Q2 2021 | $205,000 | -14.2% | 1,566 | 0.0% | 0.03% | -22.7% |
| Q1 2021 | $239,000 | +12.2% | 1,566 | 0.0% | 0.04% | -30.2% |
| Q4 2018 | $213,000 | -50.5% | 1,566 | 0.0% | 0.06% | -41.7% |
| Q3 2018 | $430,000 | +32.7% | 1,566 | 0.0% | 0.11% | +25.6% |
| Q2 2018 | $324,000 | +51.4% | 1,566 | 0.0% | 0.09% | +45.8% |
| Q4 2017 | $214,000 | +5.9% | 1,566 | -6.0% | 0.06% | +3.5% |
| Q2 2017 | $202,000 | -1.0% | 1,666 | -16.6% | 0.06% | -19.7% |
| Q3 2016 | $204,000 | -14.3% | 1,998 | 0.0% | 0.07% | -16.5% |
| Q2 2016 | $238,000 | +11.2% | 1,998 | 0.0% | 0.08% | +3.7% |
| Q1 2016 | $214,000 | -1.4% | 1,998 | 0.0% | 0.08% | -7.9% |
| Q4 2015 | $217,000 | -33.8% | 1,998 | -81.0% | 0.09% | -41.8% |
| Q1 2015 | $328,000 | – | 10,530 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |